XNCR logo
XNCR NASDAQ US

Xencor, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Dec 2013
$12.81
▲ +$0.28 (+2.23%)
Vol 607K
3
Quality Score
fail
Mkt Cap
$1.1B
ROE
-21.7%
Margin
-82.9%
D/E
21.29
Beta
0.99
52W
$7–$25

Wall Street Consensus

20 analysts · Apr 2026
6
Strong Buy
11
Buy
3
Hold
0
Sell
0
Strong Sell
85.0%
Buy Rating

Price Chart

Similar Stocks

INBX
Inhibrx Biosciences Inc
$1.1B
JANX
Janux Therapeutics Inc
$830.0M
MPLT
MapLight Therapeutics Inc
$797.0M
ORIC
Oric Pharmaceuticals Inc
$796.6M
ABUS
Arbutus Biopharma Corp
$925.1M
CGEM
Cullinan Therapeutics Inc
$611.4M
SANA
Sana Biotechnology Inc
$1.1B
SPRY
ARS Pharmaceuticals Inc
$1.2B

Earnings

Beat rate: 75.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-0.62 $-0.09 +$0.53
Sep 2025 $-0.70 $-0.08 +$0.62
Jun 2025 $-0.73 $-0.41 +$0.32
Mar 2025 $-0.61 $-0.66 $-0.05

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -26.7% -26.7% -26.7% -26.7% -21.6% -21.6%
P/E (TTM) — — — — — —
Net Margin -70.7% -113.2% -113.2% -113.2% -82.9% -82.9%
Gross Margin — — — — — —
D/E Ratio 23.38 23.38 23.38 23.38 21.29 21.29
Current Ratio 5.34 5.34 5.34 5.34 5.99 5.99

Key Ratios

ROA (TTM)
-15.4%
P/S (TTM)
6.53
P/B
2.4
EPS (TTM)
$-1.88
CF/Share
$-1.81
Rev Growth 3Y
-26.2%
52W High
$24.94
52W Low
$6.92
$6.92 52-Week Range $24.94

How does XNCR compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

XNCR AAPG ABEO ABOS ABP

XNCR valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
6.5
▼ 49% below peers (12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
2.4
▼ 4% below peers (2.5)
vs Peers
vs Industry
Fair value
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

XNCR profitability vs Biotechnology peers

ROE
-21.7%
▲ 68% above peers (-67.3%)
vs Peers
vs Industry
Top tier
Net margin
-82.9%
▲ 71% above peers (-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-15.4%
▲ 67% above peers (-46.7%)
vs Peers
vs Industry
Top tier

XNCR financial health vs Biotechnology peers

D/E ratio
21.3
▼ 0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
6.0
▲ 35% above peers (4.4)
vs Peers
vs Industry
Below avg
Beta
1.0
▲ 2% above peers (1.0)
vs Peers
vs Industry
Less volatile

XNCR fundamentals radar

XNCR Peer median Industry

XNCR profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

XNCR vs peers: key metrics

Latest News

No related news yet